Next-generation therapeutics for infectious diseases conquer the global spotlight
Resistance to current drugs spurs treatment innovation in influenza, respiratory syncytial virus, chlamydia and gonorrhoea
28-Mar-2014 -
The available antivirals for commonly occurring infections such as respiratory syncytial virus (RSV) and influenza are characterised by variable response, poor tolerability and suboptimal dosing regimens, limiting their regular use and efficacy. Likewise, the development of resistance to almost ...
bacterial infections
Chlamydia
Chlamydia trachomatis
+7